ProQR Therapeutics (PRQR)
(Delayed Data from NSDQ)
$1.99 USD
-0.01 (-0.50%)
Updated May 2, 2024 04:00 PM ET
After-Market: $1.98 -0.01 (-0.50%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/21/2024
Time: -- |
3/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, ProQR Therapeutics (PRQR) reported earnings of -$0.08 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for PRQR's next earnings release expected on May 21, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for PRQR
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
PRQR: What are Zacks experts saying now?
Zacks Private Portfolio Services